Workday Forecast, price target & analysts
Workday Target price 2025 - Analyst rating & recommendation
Workday Classifications & Recommendation:
Workday Price Target
| Target Price | $285.60 |
| Price | $222.25 |
| Potential | 28.50% |
| Number of Estimates | 41 |
| 41 Analysts have issued a price target Workday 2026 . The average Workday target price is $285.60. This is 28.50% higher than the current stock price. The highest price target is $341.25 53.54% , the lowest is $232.30 4.52% . | |
| A rating was issued by 47 analysts: 36 Analysts recommend Workday to buy, 11 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Workday stock has an average upside potential 2026 of 28.50% . Most analysts recommend the Workday stock at Purchase. |
Sales and Margin forecast 2026, 2027 to 2033
43 Analysts have issued a sales forecast Workday 2026 . The average Workday sales estimate is $9.7b . This is 5.39% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $10.0b 8.72% , the lowest is $9.3b 0.83% .
This results in the following potential growth metrics:
Revenue Estimates
| 2025 | $8.4b | 16.35% |
|---|---|---|
| 2026 | $9.7b | 15.19% |
| 2027 | $10.9b | 12.45% |
| 2028 | $12.3b | 12.13% |
| 2029 | $13.9b | 13.07% |
| 2030 | $15.5b | 11.95% |
| 2031 | $17.2b | 10.76% |
| 2032 | $19.0b | 10.63% |
| 2033 | $20.9b | 10.09% |
23 Analysts have issued an Workday EBITDA forecast 2026. The average Workday EBITDA estimate is $3.1b . This is 77.08% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $3.4b 89.19% , the lowest is $2.8b 56.87% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2025 | $825m | 77.42% |
|---|---|---|
| 2026 | $3.1b | 281.21% |
| 2027 | $3.7b | 17.01% |
| 2028 | $4.6b | 24.02% |
| 2029 | $5.0b | 10.04% |
| 2030 | $5.7b | 13.28% |
EBITDA Margin
| 2025 | 9.77% | 52.48% |
|---|---|---|
| 2026 | 32.33% | 230.98% |
| 2027 | 33.64% | 4.05% |
| 2028 | 37.21% | 10.61% |
| 2029 | 36.21% | 2.69% |
| 2030 | 36.64% | 1.19% |
43 Workday Analysts have issued a net profit forecast 2026. The average Workday net profit estimate is $2.4b . This is 101.67% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $2.7b 123.78% , the lowest is $2.1b 77.62% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2025 | $526m | 61.91% |
|---|---|---|
| 2026 | $2.4b | 363.53% |
| 2027 | $2.9b | 17.75% |
| 2028 | $3.5b | 21.99% |
| 2029 | $3.4b | 4.32% |
| 2030 | $4.4b | 30.49% |
| 2031 | $4.3b | 2.26% |
Net Margin
| 2025 | 6.23% | 67.26% |
|---|---|---|
| 2026 | 25.06% | 302.39% |
| 2027 | 26.24% | 4.71% |
| 2028 | 28.55% | 8.80% |
| 2029 | 24.16% | 15.38% |
| 2030 | 28.16% | 16.56% |
| 2031 | 24.85% | 11.75% |
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2031
43 Analysts have issued a Workday forecast for earnings per share. The average Workday EPS is $9.24 . This is 105.33% higher than earnings per share in the financial year 2025. The highest EPS forecast is $10.25 127.78% , the lowest is $8.13 80.67% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2025 | $1.95 | 62.50% |
|---|---|---|
| 2026 | $9.24 | 373.85% |
| 2027 | $10.87 | 17.64% |
| 2028 | $13.27 | 22.08% |
| 2029 | $12.69 | 4.37% |
| 2030 | $16.56 | 30.50% |
| 2031 | $16.19 | 2.23% |
P/E ratio
| Current | 49.39 | 11.78% |
|---|---|---|
| 2026 | 24.06 | 51.28% |
| 2027 | 20.44 | 15.05% |
| 2028 | 16.75 | 18.05% |
| 2029 | 17.51 | 4.54% |
| 2030 | 13.42 | 23.36% |
| 2031 | 13.73 | 2.31% |
Current Workday Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Rosenblatt |
➜
Neutral
|
Initiated | Dec 02 2025 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Nov 26 2025 |
| Bernstein |
Outperform
➜
Outperform
|
Unchanged | Nov 26 2025 |
| DA Davidson |
Neutral
➜
Neutral
|
Unchanged | Nov 26 2025 |
| Citigroup |
Neutral
➜
Neutral
|
Unchanged | Nov 26 2025 |
| Guggenheim |
Buy
➜
Buy
|
Unchanged | Nov 26 2025 |
| Citizens |
Market Outperform
➜
Market Outperform
|
Unchanged | Nov 26 2025 |
| Analyst Rating | Date |
|---|---|
|
Initiated
Rosenblatt:
➜
Neutral
|
Dec 02 2025 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Nov 26 2025 |
|
Unchanged
Bernstein:
Outperform
➜
Outperform
|
Nov 26 2025 |
|
Unchanged
DA Davidson:
Neutral
➜
Neutral
|
Nov 26 2025 |
|
Unchanged
Citigroup:
Neutral
➜
Neutral
|
Nov 26 2025 |
|
Unchanged
Guggenheim:
Buy
➜
Buy
|
Nov 26 2025 |
|
Unchanged
Citizens:
Market Outperform
➜
Market Outperform
|
Nov 26 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
